An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Establishment Labs Holdings Inc. (NASDAQ: ESTA) announced its participation in two investment conferences. CEO Juan José Chacón-Quirós and Interim CFO Raj Denhoy will attend the Jefferies London Healthcare Conference on November 16, 2021, and the Canaccord Genuity Virtual MedTech Forum on November 18, 2021. Live webcasts of their presentations will be available on the Establishment Labs investor relations website, with archived versions accessible afterward. The company specializes in breast aesthetics and reconstruction, offering innovative silicone gel-filled implants globally.
Positive
Participation in major investment conferences may enhance visibility and investor interest.
Establishment Labs has delivered over 1.8 million Motiva Implants to plastic surgeons in more than 80 countries, indicating strong market penetration.
Negative
None.
SANTA BARBARA, Calif.--(BUSINESS WIRE)--
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the 2021 Jefferies London Healthcare Conference which is being held November 16-19, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak in-person to conference attendees at 12:20 pm GMT on Tuesday, November 16, 2021.
Mr. Chacón-Quirós and Mr. Denhoy will also participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum being held on November 18, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak via webcast to conference attendees at 2:00 pm ET on Thursday, November 18, 2021.
Live webcasts of the presentations will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. Archived versions of the webcasts will be available on the same website following the completion of the events.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness. The company’s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants® that include a number of innovative and patented features designed to deliver improved aesthetic and clinical outcomes. Since commercial launch in 2010, more than 1.8 million Motiva Implants® have been delivered to plastic surgeons in over 80 countries. The company also offers or has under development a number of related products and technologies, including the Motiva Flora® tissue expander and Motiva MIA®, the company’s minimally invasive breast enhancement procedure. In 2018, Establishment Labs received an investigational device exemption (IDE) from the FDA for the Motiva Implant® and began a clinical trial to support regulatory approval in the United States. Motiva Implants® are manufactured at the company’s two facilities in Costa Rica, which are compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. Please visit our website for additional information at www.establishmentlabs.com.
What investment conferences will Establishment Labs participate in 2021?
Establishment Labs will participate in the Jefferies London Healthcare Conference on November 16, 2021, and the Canaccord Genuity Virtual MedTech Forum on November 18, 2021.
Who from Establishment Labs is attending the investment conferences?
CEO Juan José Chacón-Quirós and Interim CFO Raj Denhoy will represent Establishment Labs at the conferences.
Where can I watch the presentations by Establishment Labs executives?
Live webcasts of the presentations will be available on the Establishment Labs investor relations website.
How many Motiva Implants has Establishment Labs delivered?
Establishment Labs has delivered more than 1.8 million Motiva Implants since its commercial launch.
What is the focus of Establishment Labs?
Establishment Labs focuses on improving women’s health through breast aesthetics and reconstruction.
